CLINCHAT Trademark

Trademark Overview


On Friday, August 11, 2023, a trademark application was filed for CLINCHAT with the United States Patent and Trademark Office. The USPTO has given the CLINCHAT trademark a serial number of 98128644. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2024. This trademark is owned by ProPharma Group Holdings, LLC. The CLINCHAT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consulting services for others in the field of design, planning, and implementation project management of scientific research, clinical trials, clinical trial simulation, and clinical trial data review; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of a web-based software application for providing electronic data capture ("EDC") of clinical research data; Software as a service (SAAS) services featuring software for providing access to publications, clinical trials, white papers, studies, and regulations in the fields of pharmacology, medicine, healthcare, and biotechnology; Technical support services, namely, troubleshooting of computer software problems
clinchat

General Information


Serial Number98128644
Word MarkCLINCHAT
Filing DateFriday, August 11, 2023
Status700 - REGISTERED
Status DateTuesday, September 10, 2024
Registration Number7504378
Registration DateTuesday, September 10, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements


Pseudo MarkCLINICAL CHAT
Goods and ServicesConsulting services for others in the field of design, planning, and implementation project management of scientific research, clinical trials, clinical trial simulation, and clinical trial data review; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of a web-based software application for providing electronic data capture ("EDC") of clinical research data; Software as a service (SAAS) services featuring software for providing access to publications, clinical trials, white papers, studies, and regulations in the fields of pharmacology, medicine, healthcare, and biotechnology; Technical support services, namely, troubleshooting of computer software problems

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 11, 2023
Primary Code042
First Use Anywhere DateThursday, January 4, 2024
First Use In Commerce DateThursday, January 4, 2024

Trademark Owner History


Party NameProPharma Group Holdings, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressOverland Park, KS 66210

Party NameProPharma Group Holdings, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOverland Park, KS 66210

Party NameProPharma Group Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOverland Park, KS 66210

Trademark Events


Event DateEvent Description
Tuesday, August 15, 2023NEW APPLICATION ENTERED
Monday, September 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 19, 2023ASSIGNED TO EXAMINER
Thursday, September 28, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, September 28, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, September 28, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 28, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, September 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 8, 2024USE AMENDMENT FILED
Wednesday, May 8, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, June 13, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 13, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 8, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, August 8, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 10, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED